[Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002].
Outbreaks of Ebola virus haemorrhagic fever have been reported from 1994 to 1996 in the province of Ogooué Ivindo, a forest zone situated in the Northeast of Gabon. Each time, the great primates had been identified as the initial source of human infection. End of November 2001 a new alert came from this province, rapidly confirmed as a EVHV outbreak. The response was given by the Ministry of Health with the help of an international team under the aegis of WHO. An active monitoring system was implemented in the three districts hit by the epidemic (Zadié, Ivindo and Mpassa) to organize the detection of cases and their follow-up. A case definition has been set up, the suspected cases were isolated at hospital, at home or in lazarets and serological tests were performed. These tests consisted of the detection of antigen or specific IgG and the RT-PCR. A classification of cases was made according to the results of biological tests, clinical and epidemiological data. The contact subjects were kept watch over for 21 days. 65 cases were recorded among which 53 deaths. The first human case, a hunter died on the 28th of October 2001. The epidemic spreads over through family transmission and nosocomial contamination. Four distinct primary foci have been identified together with an isolated case situated in the South East of Gabon, 580 km away from the epicenter. Deaths happened within a delay of 6 days. The last death has been recorded on the 22nd of March 2002 and the end of the outbreak was declared on the 6th of May 2002. The epidemic spreads over the Gabon just next. Unexplained deaths of animals had been mentionned in the nearby forests as soon as August 2001: great primates and cephalophus. Samples taken from their carcasses confirmed a concomitant animal epidemic.
Nkoghe
D
D
Ministère de la santé publique, Libreville, Gabon.
Formenty
P
P
Leroy
E M
EM
Nnegue
S
S
Edou
S Y Obame
SY
Ba
J Iba
JI
Allarangar
Y
Y
Cabore
J
J
Bachy
C
C
Andraghetti
R
R
de Benoist
A C
AC
Galanis
E
E
Rose
A
A
Bausch
D
D
Reynolds
M
M
Rollin
P
P
Choueibou
C
C
Shongo
R
R
Gergonne
B
B
Koné
L M
LM
Yada
A
A
Roth
C
C
Mve
M Toung
MT
D000818:Animals; D000866:Antelopes / Q000821:virology; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D016000:Cluster Analysis; D016358:Contact Tracing; D003428:Cross Infection / Q000453:epidemiology / Q000635:transmission; D004196:Disease Outbreaks; D004197:Disease Reservoirs; D029043:Ebolavirus / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity; D005500:Follow-Up Studies; D005516:Food Microbiology; D005681:Gabon / Q000453:epidemiology; D006071:Gorilla gorilla / Q000821:virology; D000882:Haplorhini / Q000821:virology; D019142:Hemorrhagic Fever, Ebola / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality / Q000517:prevention & control / Q000635:transmission / Q000662:veterinary; D006801:Humans; D007391:International Cooperation; D008460:Meat / Q000821:virology; D010356:Patient Isolation; D046328:Porcupines / Q000821:virology; D018419:Primate Diseases / Q000453:epidemiology* / Q000635:transmission / Q000821:virology; D011323:Primates / Q000821:virology*; D011790:Quarantine; D012367:RNA, Viral / Q000097:blood; D012189:Retrospective Studies; D012698:Serologic Tests; D014944:World Health Organization
D000914:Antibodies, Viral; D012367:RNA, Viral